Oral tumors Flashcards
Oral tumors are the ___ most common cancer in dogs
What percentage of all canine cancer?
What percentage of all feline cancer?
4th
6-7% of all canine cancer; 3% of all feline
Oropharyngeal tumors ___x more common in dogs than cats; __x more common in male dogs
- 6
- 4
2 oral tumors more common in male dogs?
Malignant melanoma, Tonsilar SCC, peripheral odontogenic fibroma more common in male dogs
Axial OSA in female dogs
List 9 breeds at risk for oropharyngeal cancer?
Cocker spaniel
GSD
German Shorthair Pointer
Weimaraner
Golden retriever
Gordon setter
Mini poodle
Chow Chow
Boxer
List 4 most common oral malignancies?
Malignant Melanoma
SCC
Fibrosarcoma
Acanthomatous Ameloblastoma
List 2 most common oral malignancies in cats?
SCC
Fibrosarcoma
List 2 canine oral tumors associated with best prognosis?
List 4 features associated with good prognosis?
Local recurrence %
Acanthomatous ameloblastoma, OSCC
Complete resection, rostral location, smaller diameter, earlier stage
Local recurrence 30%, function of tumor size (1: 3: 8x as likely to recur for T 1: 2: 3)
List 2 canine oral tumors assciated with worse prognosis?
What feature is associated with survival?
fibrosarcoma, melanoma
Size associated with survival (3yr PFS 55% T1, 32% T2, 20% T3)
Fibrosarcoma typically poor prognosis and high rate of recurrence post-op; requires add’l tx – chemo / radiation
Melanoma typically well controlled locally but metastatic disease req additional therapy
History and clinical signs associated with canine oral tumors?
mass in mouth, facial swelling, exophthalmos
- cervical LN enlargement (SCC)
- salivation, ,epistaxis, halitosis, bloody oral discharge
- dysphagia, weight loss, loose teeth
- rare hypercalcemia, hyperglycemia
Canine malignant melanoma
Breed predilection? Cats?
Sex predilection? Age?
Amelanotic cases?
IHC marker?
Metastasis?
only common oral tumor with small breed predilection (Cocker, mini schnauzer, Anatolian sheepdog, Gordon setter, chow, golden retriever),
rare in cats
* possible male predilection, older dogs (11.4 yrs)
* 1/3 of cases are amelanotic
* IHC with Melan A, PNL2, TRP1, TRPS - 100% specific and 94% sensitive
* Highly malignant (LN’s or lungs up to 80%; lungs 13-67%)
4 prognostic indicators for canine oropharyngeal tumors?
Recurrence rate with surgery for mandible and maxilla?
-No tx? Sx alone? T1 vs. T2-3?
With RT control?
Prognostic indicators: WHO stage, nuclear atypia, mitotic index, location (lip/tongue less metastatic
* with surgery – recurrence 22% (mandibular) to 48% (maxilla)
- no tx: MST 64 d
- sx alone MST 150-318d (5-10 mo); <35% survival @ 1 yr
- T1 MST 511d; T2-3 or any node à 164d
* with RT: 83-100% control; 70% CR
- Median local recurrence 139 d; recurrence 15-26%
- Poor RT risk factors: non-rostral, bone lysis, macroscopic dz
- death from metastatic disease
- feline melanoma 60% response; MST 146
SCC
__ most common in cats, __ in dogs
3 Risk factors?
* 1st most common in cats, 2nd in dogs
* Risk factors – 4x flea collars, canned food (tuna), 2-fold increased risk cigarette smoke
- p53 mutations may be related to smoke-related risk
* invasive to bone, particularly in cats
- increased expression PTHrP promotes bone invasion, resorption, paran eoplastic hypercalcemia has been reported
Feline oral SCC
Metastasis?
MST?
Prognosis for mandibular tumors
- Rarely metastatic (may be under-estimated in cats d/t generally poor control of primary disease)
- MST’s in the range of 1-3 months with <10% 1yr survival, regardless of tx (sx, RT, chemo)
- Improved prognosis for mandibular tumors (911 for rostral T, 217 with hemimandib, 192 if >50% mandible removed
- Tx with radiosensitizers reported but not significant improvements
- Strontium therapy may be effective for small tumors
- Chemo ineffective, but one study showed improvement with NSAIDs
Canine oral SCC
Metastatic rate? Tongue or tonsillar?
Prognosis with surgery for maxilla? mandible?
Definitive RT?
5 different histologies subtypes: conventional, papillary, basaloid, adenosquamous, spindle cell
Pappillary - young 9 month old and rostral oral cavity
local tumor control most challenging, mandibular better
- 20% metastatic (primarily if tongue or tonsillar – 73%)
- w Sx – maxillary 10-19mo; 57% 1-yr survival
– mandibular 29-26mo; 91% 1-yr survival
- w definitive RT – 31% recurrence
– MST RT alone à 15-16mo; + Sx à 34mo
- young age is favorable prognosis (1080 vs 315 if <>9yo)
- chemo if bulky, metastatic, or incomplete resection, or owner choice
- piroxicam 2/17 (17%) response – MST responders 180d
- Piroxicam + cisplatin (a) 56% response; MST responders 272 vs 116 non-responders (b) 57% response; 534d f/u
Osteosarcoma
Axial represents what % of all OSA?
Prognosis better for axial or appendicular?
MST with mandibulectomy? maxillectomy?
Most common cause of death?
Favorable prognostic factors?
25%
* appx 50% of axial cases are oral - mandibular (27%); maxilla (16-22%)
* prognosis better than for axial (lower rate of metastasis)
* Mandibulectomy alone MST 14-18mo; maxillectomy MST 5-10 months
* Local recurrence most common cause of death, particularly in dogs with maxillary tumors
* Complete surgical excision with margins à 1503 days DFI vs 128 with incomplete margins
* Favorable prognostic factors include: complete excision, mandibular location, small body weight
Oral FSA
___ most common in cats, ___ in dogs (esp large breeds)
Breeds?
Sex predilection?
Mean age?
High-low?
Metastasis?
2nd most common in cats, 3rd in dogs (esp large breeds)
golden retrievers and labs
possible male predilection
middle-age dogs (7.3 – 8.6 yr)
high-low common (histologically low, biologically high grade)
* always treat oral fibroma or fibrosarcoma aggressively
* 30% metastatic to lungs or regional LN
Canine oral FSA
Prognosis?
What is more problematic, local control or metastasis?
Metastasis to LN? Lungs?
Local recurrence mandible? Maxilla?
1-year survival? Mandible? Maxilla?
Sx + RT? Local recurrence?
Dogs – prognosis guarded
- local control more problematic than metastasis
- mets: LN 19-22%; lungs 27%
- local recurrence (dog) post-op 59% mandib; 40% max
- canine 1-yr survival 50% with mandib; MST 11 mand – 12 mo maxillary
- best outcomes with Sx + RT (local recurrence reduced to 32%; MST 18-26mo)
- Sx+RT - smaller tumors – better outcome T1 45mo MST; T2 31 mo; T3 7mo
Feline oral FSA
MST with mandibulectomy?
mandibulectomy (5 cats) à MST 859 d (2.3 yr)
Better outcome than dogs
Peripheral Odontogenic Fibroma
Common in __? Rare in __?
Age for dogs and cats?
Predilection?
Behaivour?
* Used to be called fibromatous/ossifying epulis
* common in dogs, rare in cats
* middle age dogs (8-9yo), young cats (<3yo)
* possible male predilection
* slow growing/benign
Predilection for rostral maxilla to third premolar teeth
* firm, covered in intact epithelium
* maxillary – rostral to 3rd premolar
Acanthomatous Ameloblastoma
Behaivour?
Breeds?
Age?
Previously called?
* Locally aggressive, non-metastatic
* Maxillary or mandibular (rostral mandible most)
* Sheltie, Old English Sheepdog
* 7-10 year old
* previously called acanthomatous epulis/adamantinoma
Diagnostics for oral tumors
Diagnostics: biopsy!!
- tRads (melanoma, tonsillar / caudal oral SCC)
- LN cytology in all oral tumors (40% metastatic melanoma palpate N; 49% N melanoma ln’s palpate enlarged)
- regional nodes: mandiblar, parotid, medial retropharyngeal
- only mandibulars are palpable, and only 30-50% of metastatic nodes are mandibular
- regional rads (but bone lysis not radiologically evident until 40% destroyed)
- CT/MRI for sx planning, tumor extent
- commonly inflamed / infected / necrotic, so get a big sample, but avoid normal tissue that cannot be resected
Treatment for oral tumors
What tumor do you not need bone resection?
Margins?
Post-op risks?
Surgery
* except peripheral odontogenic fibromas, resect bone
* 2cm margins for malignant tumors, more in feline SCC
* blood loss, hypotension risks during sx
* post op risks: dehiscence, epistaxis, ásalivation, mandib. drift (à affected side), mal-occlusion, prehension difficulty
* feeding tubes required in cats with any mandibulectomy, rarely needed in dogs
* regional lymphadenectomy benefit is unknown
* cryosurgery for lesions <2cm that are fixed and minimally invasive to bone
* aggressive lesions w/cryosurgery risk fracture or oronasal fistula if aggressively frozen
Radiation therapy for oral tumors
Radiaiton responsive tumors?
Radiaiton unresponsive tumors?
Radiation Therapy
* Very effective – best for T1 (<2cm), T2 (2-4cm)
* Can be primary or adjunct therapy
* radiation responsive: melanoma, canine OSCC, acanthomatous ameloblastoma
* radiation unresponsive: canine fibrosarc, feline OSCC
* radiation sensitizers – feline gemzar, etanidazole (gemzar not recommended d/t hematologic and local toxicity); canine – platinum drugs
* Melanoma à responds best to course fraction: > 8Gy responds much better than <4Gy
* Acute effects common, self limiting
* Hyperthermia has been used as adjunct to radiation, but offers no benefit alone over cryosurgery or surgery
Chemotherapy is indicated for what oral tumors?
Tonsillar SCC in dogs and cats, oral melanoma in dogs
* Feline OSCC expresses cox-2 but studies haven’t documented benefit from NSAIDS/piroxicam
- liposome encapsulated cisplatin not effective
- some potential with RT combined with mitoxantrone
* Canine OSCC shows some response to piroxicam; piroxicam also increases response to platinum drugs
* Oral Malig Melanoma – immunotherapy